The bill requires the President to identify foreign persons who the United States determines 'knowingly and directly' engaged in or facilitated forced organ harvesting in the People’s Republic of China and to apply targeted penalties. Those measures include blocking property using authorities under the International Emergency Economic Powers Act and making listed aliens inadmissible to, and revokable from, the United States.
The statute also directs a year‑one interagency report on China’s transplant system (including transplant volumes, donor counts, procurement timelines, U.S. research grants, and whether the conduct meets the Elie Wiesel Act’s definition of an atrocity), creates humanitarian and intelligence exceptions, authorizes case-by-case presidential waivers with periodic reporting, excludes import restrictions, and sunsets the sanctions authority after five years. That combination gives policymakers new tools while preserving narrow exceptions and executive discretion.
At a Glance
What It Does
The bill directs the President to compile a list of foreign individuals and entities that knowingly and directly engaged in or facilitated forced organ harvesting in China, then block their U.S. property under IEEPA and render listed aliens inadmissible and subject to immediate visa revocation. It also requires an interagency report on Chinese organ‑transplant policies and practices and establishes narrow exceptions for humanitarian and intelligence activities, plus a presidential waiver process.
Who It Affects
Primary targets are foreign persons—officials, medical facilities, and intermediaries—linked to organ procurement in China; U.S. financial institutions and other parties that hold or clear assets tied to listed persons face compliance obligations. The State Department, HHS, NIH, and the National Institutes also must produce and use new reporting and investigatory information.
Why It Matters
The bill leverages financial and immigration tools to pressure actors tied to alleged atrocities while creating formal U.S. data-gathering requirements about China’s transplant system. It narrows sanctions to persons rather than trade in goods, shaping how Washington balances human rights accountability and broader economic ties.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The core mechanism is a two-part enforcement-and-reporting structure. First, the President must identify foreign persons that the United States determines have knowingly and directly engaged in or facilitated forced organ harvesting inside the People’s Republic of China.
The statute instructs the administration to submit that list to specified congressional committees and to update it as new information emerges and at least annually. For each person on the list the President must use IEEPA authorities to block and prohibit transactions in property and interests in property that are in, or come into, U.S. jurisdiction or are in the possession or control of U.S. persons.
The bill makes listed aliens inadmissible and subjects their visas and entry documents to automatic revocation, while preserving narrow exceptions (UN headquarters obligations) and broader humanitarian and intelligence exemptions.
The bill layers accountability and oversight. Violations of regulations implementing the blocking orders carry civil and criminal penalties available under IEEPA.
The President can waive sanctions on a case-by-case national security basis, but must report to Congress on use of waivers every 120 days once the listing process begins. The sanctions authority itself sunsets five years after enactment, so the regime is explicitly temporary unless reauthorized.Separately, the State Department—working with HHS and NIH—must produce a comprehensive unclassified report within one year on China’s organ‑transplant policies and practices.
That report must address legal and practical transplant policies, annual transplant and donor estimates, an assessment of organ sources and procurement timelines (including whether speed of access suggests nonvoluntary sourcing), a ten‑year inventory of U.S. grants that supported transplant research with Chinese counterparts, and a determination whether the conduct rises to an ‘‘atrocity’’ under the Elie Wiesel Genocide and Atrocities Prevention Act.Finally, the bill draws a bright line on trade by prohibiting the use of this statute to impose sanctions on imported goods. It includes a classified annex option for lists and reports where necessary but otherwise emphasizes unclassified reporting to Congress.
Taken together, the law creates a primarily person‑focused sanctions and information program aimed at documenting and denying safe haven and financial access to those linked to forced organ harvesting in China.
The Five Things You Need to Know
The President must submit an initial list of foreign persons who 'knowingly and directly' engaged in or facilitated forced organ harvesting within 180 days of enactment and then update it annually and as new information becomes available.
For persons on the list the bill requires blocking of property and prohibition of transactions under IEEPA (with IEEPA penalties available for violations).
An alien placed on the list is inadmissible to the United States and subject to immediate visa revocation under INA section 221(i), with a narrow exception for obligations like UN Headquarters agreements.
The President may grant case‑by‑case waivers in the national security interest, but must report to Congress every 120 days on waiver use; the statute also exempts authorized U.S. intelligence and law‑enforcement activities and humanitarian transactions.
The Secretary of State, with HHS and NIH, must deliver a report within one year detailing transplant volumes, donor counts, organ sourcing, U.S. grants relating to Chinese transplantation research, and whether forced organ harvesting qualifies as an 'atrocity'; the sanctions authority sunsets after five years and the bill forbids imposing sanctions on the importation of goods.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
This is the formal name provision: the statute will be cited as the 'Falun Gong and Victims of Forced Organ Harvesting Protection Act.' It has no operative effect but signals the law’s focus and intent to users and readers.
Definitions
Defines key terms used through the statute, including 'forced organ harvesting' (removal of organs by coercion, abduction, deception, fraud, or abuse of power), 'organ' (as in the National Organ Transplant Act), 'foreign person', 'United States person', and 'knowingly' (includes actual knowledge or that a person should have known). The 'should have known' standard broadens potential culpability beyond proven intent and will matter for how aggressively the administration compiles the list.
Listing, sanctions, exceptions, waivers, penalties, and sunset
This is the operative sanctions regime. It requires the President to submit and maintain a list of foreign persons who knowingly and directly engaged in or facilitated forced organ harvesting in China; for each listed person the President must block property and transactions under IEEPA and make listed aliens inadmissible and subject to immediate visa revocation. The provision invokes IEEPA blocking powers while waiving the Act’s section 202 procedural requirement, and attaches IEEPA’s criminal and civil penalties to enforcement regulations. The statute creates enumerated exceptions—authorized intelligence and law‑enforcement activities, humanitarian assistance and related financial transactions, and obligations under the UN Headquarters agreement—and authorizes the President to waive sanctions on national security grounds, subject to reporting. The authority to sanction under this section terminates five years after enactment.
Interagency report on China’s organ-transplant policies and practices
Requires the Secretary of State, in consultation with HHS and the NIH Director, to produce a detailed report within one year about legal and practical organ‑transplantation policies in China. Required elements include estimates of annual transplant volume and voluntary donors, assessments of organ sources and procurement times (to identify implausibly rapid matching that could indicate nonvoluntary sourcing), a ten‑year list of U.S. grants supporting transplant research with Chinese partners, and a determination whether the conduct constitutes an 'atrocity' under the Elie Wiesel Act. The report must be unclassified with an optional classified annex. This provision both informs listing decisions and creates a public record for oversight.
Importation exception and definitions for 'goods'
Explicitly bars the statute from being used to impose sanctions on the importation of goods, defining 'good' broadly to include manufactured products and materials but excluding technical data. By removing trade sanctions from the toolset, the provision narrows U.S. leverage to person‑based financial and immigration measures rather than hitting cross-border goods flows.
This bill is one of many.
Codify tracks hundreds of bills on Foreign Affairs across all five countries.
Explore Foreign Affairs in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Prisoners of conscience and alleged victims (including Falun Gong practitioners): The statute creates an accountability pathway—denying listed individuals U.S. visas and access to the U.S. financial system and increasing political and reputational costs for implicated actors.
- Human rights and advocacy organizations: The required unclassified reporting and the public listing mechanism provide new evidence and leverage for advocacy, litigation, and international awareness campaigns.
- U.S. policymakers and Congress: The bill supplies structured intelligence, public reporting, and a defined sanctions toolset that officials can use to hold accountable overseas actors and to inform broader diplomatic strategy.
- Global transplant ethics and medical communities: The mandated HHS/NIH involvement and reporting requirements aim to clarify research linkages and donor statistics, supporting international efforts to strengthen ethical transplant standards and deter illicit organ markets.
Who Bears the Cost
- Listed foreign persons and associated entities (Chinese hospitals, officials, brokers): They face asset freezes in U.S. jurisdiction, transaction bans, visa revocation, and reputational harm which can disrupt international banking, travel, and partnerships.
- U.S. financial institutions and compliance teams: Banks, payment processors, and custodians will need to screen for listed persons and block assets, increasing compliance workloads and potential exposure to IEEPA enforcement risk.
- U.S. executive-branch agencies (State, Treasury, HHS, NIH): Agencies must devote staff time and analytic resources to compiling lists, producing detailed interagency reports, managing waiver reporting every 120 days, and handling visa‑revocation processes.
- Academic and research partners: U.S. institutions that previously collaborated on transplant research with Chinese counterparts will face reputational scrutiny and possible administrative review because the report requires an inventory of U.S. grants supporting such research over the prior ten years.
Key Issues
The Core Tension
The bill tries to balance the need to hold alleged perpetrators accountable and to create public documentation against the risk of misidentifying actors and undermining cooperation on public health and intelligence; tighter standards and transparency strengthen legitimacy but hinder rapid action, while broader discretion enables enforcement but increases the chance of error and diplomatic blowback.
The statute raises several implementation and policy tensions. First, the 'knowingly' definition includes a 'should have known' standard, lowering the bar to identify and list actors but increasing the risk of misattribution or politically motivated listings.
Administration analysts will need credible, often classified evidence to meet that standard while Congress has mandated unclassified reporting—an immediate transparency versus operational secrecy trade‑off. The availability of a classified annex helps, but it also concentrates the most sensitive evidence outside public view, making external validation harder.
Second, narrowing the toolset to person‑based financial and immigration measures (and excluding import restrictions) limits blunt economic pressure but creates enforcement challenges: listed actors can operate through third‑country intermediaries, and prosecuting IEEPA violations requires tracing often complex cross‑border financial flows. The statutory waiver and intelligence exceptions introduce necessary flexibility but also create potential perception problems: broad or frequent waivers could blunt deterrence and expose the administration to congressional scrutiny.
Finally, compiling reliable transplant statistics and donor-source data in a closed system presents methodological hurdles—estimates may remain contested, and the 'procurement timeline' metric the bill requests will demand careful contextual analysis to avoid misleading conclusions.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.